Related Experiment Videos
A sensitive ELISA for von Willebrand factor (vWf:Ag)
Summary
A new enzyme-linked immunosorbent assay (ELISA) precisely measures von Willebrand factor (vWf:Ag). This sensitive assay offers improved detection limits compared to traditional methods for diagnosing von Willebrand disease.
Area of Science:
- Biochemistry
- Immunology
- Hematology
Background:
- Accurate measurement of von Willebrand factor antigen (vWf:Ag) is crucial for diagnosing and managing von Willebrand disease.
- Existing methods like electro-immunoassay (EIA) have limitations in sensitivity and precision.
- Development of a more sensitive and precise assay is needed for improved clinical utility.
Purpose of the Study:
- To develop and validate a sensitive and precise enzyme-linked immunosorbent assay (ELISA) for quantifying von Willebrand factor antigen (vWf:Ag).
- To compare the performance of the developed ELISA with existing electro-immunoassay (EIA) methods.
- To assess the assay's utility in plasma samples from healthy individuals and patients with different types of von Willebrand disease.
Main Methods:
- A microtitre plate-based sandwich ELISA technique was employed using specific antibodies.
- Coating antibodies captured vWf:Ag from plasma and factor VIII concentrates.
- Detection of bound vWf:Ag was achieved using a peroxidase-conjugated antibody fragment (F(ab')2).
Main Results:
- The developed ELISA demonstrated a sensitivity limit of 0.004 IU/ml, significantly lower than EIA.
- High precision was observed with an inter-run imprecision of 5.1% (CV%) at 0.50 IU/ml.
- Excellent correlation (r=0.967) was found between ELISA and EIA in healthy individuals.
- The assay accurately detected low vWf:Ag levels in homozygous recessive von Willebrand disease and showed good agreement with EIA in type I patients (r=0.899).
Conclusions:
- The developed sandwich ELISA is a sensitive and precise method for measuring vWf:Ag in plasma and factor VIII concentrates.
- This assay offers superior sensitivity compared to EIA and previously reported polyclonal ELISAs.
- The assay's performance in patient samples suggests its potential for improved diagnosis and management of von Willebrand disease.